NEWS
Telix to raise $300m and set to list on Nasdaq
MELBOURNE: Telix Pharmaceuticals, the developer of cancer treatments and a favourite of local ... read more
ACCC overstates chemist merger risks claims Barrenjoey
MELBOURNE: The competition regulator entirely ignored a major wholesaler when it warned that ... read more